199 related articles for article (PubMed ID: 7076010)
1. Comparison of the composition of faecal fluid in Crohn's disease and ulcerative colitis.
Schilli R; Breuer RI; Klein F; Dunn K; Gnaedinger A; Bernstein J; Paige M; Kaufman M
Gut; 1982 Apr; 23(4):326-32. PubMed ID: 7076010
[TBL] [Abstract][Full Text] [Related]
2. Organic anions and the diarrhea of inflammatory bowel disease.
Vernia P; Gnaedinger A; Hauck W; Breuer RI
Dig Dis Sci; 1988 Nov; 33(11):1353-8. PubMed ID: 3180970
[TBL] [Abstract][Full Text] [Related]
3. Comparison of fecal granulocyte excretion in ulcerative colitis and Crohn's colitis.
Saverymuttu SH; Hodgson HJ; Chadwick VS
Dig Dis Sci; 1984 Nov; 29(11):1000-4. PubMed ID: 6489079
[TBL] [Abstract][Full Text] [Related]
4. BODY COMPOSITION IN PATIENTS WITH CROHN'S DISEASE AND ULCERATIVE COLITIS.
Back IR; Marcon SS; Gaino NM; Vulcano DSB; Dorna MS; Sassaki LY
Arq Gastroenterol; 2017; 54(2):109-114. PubMed ID: 28198913
[TBL] [Abstract][Full Text] [Related]
5. Fecal radioiodide excretion following intravenous injection of 131-I-albumin and 125-I-immunoglobulin G in chronic inflammatory bowel disease. An aid to topographic diagnosis.
Jarnum S; Jensen KB
Gastroenterology; 1975 Jun; 68(6):1433-44. PubMed ID: 1132626
[TBL] [Abstract][Full Text] [Related]
6. Serum nitrate levels in ulcerative colitis and Crohn's disease.
Oudkerk Pool M; Bouma G; Visser JJ; Kolkman JJ; Tran DD; Meuwissen SG; Peña AS
Scand J Gastroenterol; 1995 Aug; 30(8):784-8. PubMed ID: 7481547
[TBL] [Abstract][Full Text] [Related]
7. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.
Daig R; Andus T; Aschenbrenner E; Falk W; Schölmerich J; Gross V
Gut; 1996 Feb; 38(2):216-22. PubMed ID: 8801200
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
9. Concanavalin A-binding cholesterol crystallization inhibiting and promoting activity in bile from patients with Crohn's disease compared to patients with ulcerative colitis.
Keulemans YC; Mok KS; Slors JF; Brink MA; Gouma DJ; Tytgat GN; Groen AK
J Hepatol; 1999 Oct; 31(4):685-91. PubMed ID: 10551393
[TBL] [Abstract][Full Text] [Related]
10. Sodium and potassium excretion in patients with ileostomies.
Svaninger G; Nordgren S; Palselius IR; Fasth S; Hultén L
Eur J Surg; 1991 Oct; 157(10):601-5. PubMed ID: 1687252
[TBL] [Abstract][Full Text] [Related]
11. Histochemical demonstration of desialation and desulphation of normal and inflammatory bowel disease rectal mucus by faecal extracts.
Rhodes JM; Black RR; Gallimore R; Savage A
Gut; 1985 Dec; 26(12):1312-8. PubMed ID: 2867955
[TBL] [Abstract][Full Text] [Related]
12. Faecal proteolysis of albumin and IgG in Crohn's disease and ulcerative colitis.
Soltoft J; Jarnum S
Digestion; 1969; 2(5):282-8. PubMed ID: 5365260
[No Abstract] [Full Text] [Related]
13. THE ONSET OF CLINICAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS.
Nóbrega VG; Silva INN; Brito BS; Silva J; Silva MCMD; Santana GO
Arq Gastroenterol; 2018; 55(3):290-295. PubMed ID: 30540094
[TBL] [Abstract][Full Text] [Related]
14. Bile acid studies in patients with Crohn's colitis.
Rutgeerts P; Ghoos Y; Vantrappen G
Gut; 1979 Dec; 20(12):1072-7. PubMed ID: 527881
[TBL] [Abstract][Full Text] [Related]
15. Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease.
Nishida Y; Murase K; Isomoto H; Furusu H; Mizuta Y; Riddell RH; Kohno S
Hepatogastroenterology; 2002; 49(45):678-82. PubMed ID: 12063968
[TBL] [Abstract][Full Text] [Related]
16. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
Szewczuk MR; Depew WT
Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
[TBL] [Abstract][Full Text] [Related]
17. Differential excretion of leucocyte granule components in inflammatory bowel disease: implications for pathogenesis.
Dwarakanath AD; Finnie IA; Beesley CM; O'Dowd GM; Nash J; Tsai HH; Parker N; Rhodes JM
Clin Sci (Lond); 1997 Mar; 92(3):307-13. PubMed ID: 9093012
[TBL] [Abstract][Full Text] [Related]
18. Faecal mucus degrading glycosidases in ulcerative colitis and Crohn's disease.
Rhodes JM; Gallimore R; Elias E; Allan RN; Kennedy JF
Gut; 1985 Aug; 26(8):761-5. PubMed ID: 2991089
[TBL] [Abstract][Full Text] [Related]
19. Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study.
Stallmach A; Langbein C; Atreya R; Bruns T; Dignass A; Ende K; Hampe J; Hartmann F; Neurath MF; Maul J; Preiss JC; Schmelz R; Siegmund B; Schulze H; Teich N; von Arnim U; Baumgart DC; Schmidt C
Aliment Pharmacol Ther; 2016 Dec; 44(11-12):1199-1212. PubMed ID: 27714831
[TBL] [Abstract][Full Text] [Related]
20. Protein patterns in serum and peritoneal fluid in Crohn's disease and ulcerative colitis.
Haglund U; Hultén L
Acta Chir Scand; 1976; 142(2):160-4. PubMed ID: 936940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
